Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
45,070,886
-
Share change
-
-363,501
-
Total reported value
-
$2,146,457,308
-
Put/Call ratio
-
476%
-
Price per share
-
$47.70
-
Number of holders
-
163
-
Value change
-
-$69,029,952
-
Number of buys
-
86
-
Number of sells
-
93
Institutional Holders of TURNING POINT THERAPEUTICS I - COM (TPTX) as of Q4 2021
As of 31 Dec 2021,
TURNING POINT THERAPEUTICS I - COM (TPTX) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,070,886 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Cormorant Asset Management, LP, STATE STREET CORP, ORBIMED ADVISORS LLC, ALLIANCEBERNSTEIN L.P., FEDERATED HERMES, INC., and PICTET ASSET MANAGEMENT SA.
This page lists
163
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.